Geun Hye Yeo

Title: Geun Hye Yeo: Innovator in Hemophilia Treatment

Introduction

Geun Hye Yeo is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hemophilia. His innovative work has led to the development of a highly efficient anti-TFPI antibody composition.

Latest Patents

Geun Hye Yeo holds 1 patent for his invention titled "Highly efficient anti-TFPI antibody composition." This patent describes a pharmaceutical composition that includes an anti-TFPI antibody for treating hemophilia. The composition is notable for having a content of HCP in a drug substance of less than 10.0 ng/mg and a content of LPA in the drug substance or drug product of less than 1.0 ng/mg. The invention aims to provide a highly efficient anti-TFPI antibody composition with very low contents of HCP and LPA, which can be effectively used for treating antibody-induced hemophilia patients and preventing blood coagulation diseases.

Career Highlights

Geun Hye Yeo is associated with The Green Cross Corporation, where he continues to advance his research and development efforts. His work is pivotal in creating innovative solutions for patients suffering from hemophilia.

Collaborations

Geun Hye Yeo collaborates with talented individuals such as Min Jung Kim and Haeng Eun Song, contributing to a dynamic research environment that fosters innovation.

Conclusion

Geun Hye Yeo's contributions to the field of hemophilia treatment through his patented anti-TFPI antibody composition highlight his role as a leading inventor in the pharmaceutical industry. His work not only advances medical science but also offers hope to patients in need.